We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $928M
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
AUM
$507M
AUM Growth
+$57.7M
Cap. Flow
-$18.1M
Cap. Flow %
-3.57%
Top 10 Hldgs %
40.19%
Holding
192
New
22
Increased
37
Reduced
111
Closed
9

Top Sells

Rank Stock Value
1
OEC icon
Orion
OEC
+$4.09M
2
GIB icon
CGI
GIB
+$3.43M
3
AAPL icon
Apple
AAPL
+$2.81M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.98M
5
PFE icon
Pfizer
PFE
+$1.67M

Sector Composition

Rank Sector Weight
1 Technology 25.38%
2 Financials 14.84%
3 Healthcare 12.51%
4 Communication Services 11.1%
5 Consumer Discretionary 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDN
126
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$395K 0.08%
15,465
+1,175
+8% +$30.1K
VGT icon
127
Vanguard Information Technology ETF
VGT
$147B
$385K 0.08%
8,704
XYZ
128
Block Inc
XYZ
$47B
$370K 0.07%
1,702
+16
+0.9% +$3.12K
ISRG icon
129
Intuitive Surgical
ISRG
$132B
$364K 0.07%
1,335
-27
-2% -$6.7K
OR icon
130
OR Royalties Inc
OR
$6.03B
$349K 0.07%
27,575
ORCL icon
131
Oracle
ORCL
$413B
$339K 0.07%
5,233
+31
+0.6% +$1.84K
EWZ icon
132
iShares MSCI Brazil ETF
EWZ
$9.07B
$337K 0.07%
9,104
+335
+4% +$10.8K
FTS icon
133
Fortis
FTS
$28.6B
$321K 0.06%
7,852
-725
-8% -$29.8K
ENDP
134
DELISTED
Endo International plc
ENDP
$321K 0.06%
44,774
-4,220
-9% -$22K
ARKG icon
135
ARK Genomic Revolution ETF
ARKG
$1.63B
$318K 0.06%
+3,410
New +$272K
MA icon
136
Mastercard
MA
$505B
$315K 0.06%
882
+5
+0.6% +$1.66K
VT icon
137
Vanguard Total World Stock ETF
VT
$79.1B
$298K 0.06%
3,220
+85
+3% +$7.37K
KSU
138
DELISTED
Kansas City Southern
KSU
$287K 0.06%
1,407
+12
+0.9% +$2.25K
SU icon
139
Suncor Energy
SU
$72.4B
$285K 0.06%
16,964
-766
-4% -$11.3K
VMD icon
140
Viemed Healthcare
VMD
$363M
$273K 0.05%
34,898
-1,144
-3% -$10.1K
VAR
141
DELISTED
Varian Medical Systems, Inc.
VAR
$273K 0.05%
1,558
+15
+1% +$2.6K
DBA icon
142
Invesco DB Agriculture Fund
DBA
$1.22B
$267K 0.05%
16,550
-515
-3% -$7.82K
BAC icon
143
Bank of America
BAC
$441B
$265K 0.05%
8,752
-420
-5% -$11.3K
FINX icon
144
Global X FinTech ETF
FINX
$171M
$262K 0.05%
5,600
COST icon
145
Costco
COST
$421B
$260K 0.05%
689
+74
+12% +$27.6K
CPRI icon
146
Capri Holdings
CPRI
$1.72B
$259K 0.05%
+6,156
New +$188K
NVO
147
Novo Nordisk
NVO
$203B
$256K 0.05%
7,322
-616
-8% -$21.3K
CAT icon
148
Caterpillar
CAT
$395B
$250K 0.05%
1,372
+14
+1% +$2.37K
MCD icon
149
McDonald's
MCD
$196B
$239K 0.05%
1,115
CL icon
150
Colgate-Palmolive
CL
$74.1B
$238K 0.05%
2,779

Similar funds

Claret Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Claret Asset Management held 192 positions worth $507M, up 13% from $449M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Claret Asset Management withdrew a net $18.1M in Q4 2020, closing 9 positions and reducing 111 holdings. Its most notable exit was Kimball Electronics, an estimated $1.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Claret Asset Management opened a new position in ARK Genomic Revolution ETF worth $318K.

  • Claret Asset Management's largest Q4 2020 buy was ARK Genomic Revolution ETF: 3,410 shares worth $318K.
  • Claret Asset Management added most to Denny's in Q4 2020, an estimated $4.5M increase.
  • Claret Asset Management's biggest Q4 2020 reduction was Orion, cutting an estimated $4.09M.
  • Claret Asset Management fully exited Kimball Electronics in Q4 2020, selling an estimated $1.11M.
  • Claret Asset Management's ten largest holdings make up 40% of its $507M portfolio in Q4 2020.
  • Claret Asset Management opened 22 new positions and closed 9 in Q4 2020.
  • Claret Asset Management's portfolio value rose 13% quarter-over-quarter to $507M.

Based on Claret Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.